
Compounded · Rx required
Tirzepatide
Tirzepatide
Where are you in treatment?
$349 total · 3 Months · Automatic Refills • Cancel Anytime
Choose where you are in treatment to see your price.

The shifts, the calls, the sleep you never caught up on — it adds up. Let's fix it.
How it works

Start
Start from your phone
Answer a few questions about your health and goals.

Review
A clinician reviews your requested treatment
They decide whether treatment is appropriate. No video visit required in 41 states.

Delivered
Your treatment ships
One of our trusted pharmacy partners discreetly ships your medication to your doorstep.

What Tirzepatide can do
20.9% average weight loss in clinical trials.
Tirzepatide is a groundbreaking dual GLP-1/GIP agonist that delivers superior weight loss results. Clinical studies demonstrate average weight loss of up to 20.9% of body weight over 72 weeks.
Clinical outcomes based on published tirzepatide trials, including SURMOUNT-1 (weight loss)¹, SURPASS-2 (glucose & metabolic health)², SURPASS-4 (cardiovascular outcomes)³, and SURMOUNT-OSA (sleep apnea)⁴. Compounded versions of Tirzepatide are not associated with Eli Lilly & Company and/or its genuine MOUNJARO® and/or ZEPBOUND® products. Compounded versions of Tirzepatide are not FDA approved, and neither the FDA nor any global regulatory agency has reviewed these products for safety, quality, or efficacy. GLP-1s may cause serious side effects, including possible thyroid tumors, including cancer. See the 'Important Safety Information' links below for more details.
01Oversight
Physician reviewed
02Dose
Tirzepatide is administered as a once-weekly subcutaneous injection.
03Frequency
Weekly injection
04Included
Medication, supplies, provider messaging
Frequently asked questions
Everything else worth knowing about Tirzepatide.
Safety information
Boxed warning: thyroid C-cell tumors
- · Tirzepatide caused thyroid C-cell tumors in rodents. It is unknown whether it causes medullary thyroid carcinoma (MTC) in humans.
- · Do not use if you or a family member has had MTC, or if you have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
- · Tell your provider immediately about a neck lump or swelling, hoarseness, trouble swallowing, or shortness of breath.
About Our Medications
Our treatments contain active pharmaceutical ingredients that conform to USP (United States Pharmacopeia) monograph standards and are custom-compounded by licensed 503A and 503B pharmacies to meet your individual needs. Compounded medications are not FDA-approved finished drug products. The suggested formulations are provided for reference only and are based on formulations that have historically been prescribed by duly licensed prescribers. All medications are prepared in accordance with a valid prescription from a licensed healthcare provider following a medical consultation.
Medical Consultation Required
Our licensed medical providers will evaluate your health history and goals to determine the most appropriate treatment option for you. Prescriptions are subject to medical evaluation and are not guaranteed. If we are unable to prescribe treatment after your consultation, you pay zero. Independent clinical services provided by: Arora Health & Aesthetics • Licensed in all 50 states + DC. 300 Lenora Street, Seattle, WA 98121 • https://www.arora-health.com.
Clinical References
- 1Jastreboff AM, et al. SURMOUNT-1: Tirzepatide Once Weekly for the Treatment of Obesity. N Engl J Med. 2022;387(3):205-216.
- 2Del Prato S, Kahn SE, Pavo I, et al. Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4). Lancet. 2021;398(10313):1811-1824.
- 3Malhotra A, Grunstein RR, Gao L, et al. Tirzepatide for the treatment of obstructive sleep apnea and obesity. N Engl J Med. 2024;391(13):1193-1205.
Related treatments

Semaglutide
Proven GLP-1 medication for effective weight management
Explore treatmentMore on Tirzepatide
Deeper dives from our editorial team — pricing, dosing, and the research behind it.